Peter Pitts

Author Archive

  • Apr 14, 2026
    The FDA’s decision to decline approval of Replimune’s treatment for advanced melanoma (RP1) raises important questions about the agency’s current regulatory posture...
  • Apr 10, 2026
    Default Description | Drugwonks.com is the web log of the Center for Medicine in the Public Interest (CMPI), a forum offering rigorous and compelling research on the most critical...
  • Apr 6, 2026
    There is something too neat, almost too polished, about the way not-for-profit hospitals tell their financial story, a narrative carefully plated for public consumption with billions...
  • Apr 2, 2026
    Default Description | Drugwonks.com is the web log of the Center for Medicine in the Public Interest (CMPI), a forum offering rigorous and compelling research on the most critical...
  • Mar 31, 2026
    There is something too neat, almost too polished, about the way not-for-profit hospitals tell their financial story, a narrative carefully plated for public consumption with billions...
  • Mar 23, 2026
    Just like families across America, Georgia families depend on a stable and predictable vaccine system to keep their children safe and communities healthy. Although US Health and...
  • Mar 20, 2026
    Default Description | Drugwonks.com is the web log of the Center for Medicine in the Public Interest (CMPI), a forum offering rigorous and compelling research on the most critical...
  • Mar 18, 2026
    The Employee Retirement Income Security Act (ERISA) was designed in 1974 to protect workers’ pensions and employer-sponsored benefits. Half a century later, it still governs a...
  • Feb 27, 2026
    The U.S. Court of Appeals for the 2nd Circuit is reviewing a closely watched case involving acetaminophen, the active ingredient in Tylenol, and claims that its use during...
  • Feb 26, 2026
    The US Food and Drug Administration (FDA) will, by default, require only one clinical trial to demonstrate that a product meets its regulatory requirements for safety and efficacy in...
  • Feb 26, 2026
    The U.S. Court of Appeals for the 2nd Circuit is reviewing a closely watched case involving acetaminophen, the active ingredient in Tylenol, and claims that its use during...
  • Feb 25, 2026
    You go to the hospital to get better — not to get financially blindsided. Yet every year, millions of Americans open their mailboxes to find medical bills that make them gasp:...
  • Feb 25, 2026
    The US Food and Drug Administration (FDA) will, by default, require only one clinical trial to demonstrate that a product meets its regulatory requirements for safety and efficacy in...
  • Feb 9, 2026
    Based on a review of the applicable facts, earlier today @HHSOGC referred Hims & Hers Health, Inc. ("Hims") to the Department of Justice for investigation for potential...
  • Feb 5, 2026
    Executive Summary Problem: Foreign nations are holding America’s medicine cabinets for ransom. Today there is the very real risk of drug shortages being caused, on purpose, by...
  • Jan 16, 2026
    If the SAFE Drugs Act of 2025 makes you nervous, you should ask yourself why. Earlier this year, the Center for Medicine in the Public Interest (CMPI) published a report warning that...
  • Jan 15, 2026
    RFK, Jr’s vaccine policy is healthcare noblesse oblige of the most craven, grievous and callous variety. It’s also an opportunity to advance vaccine acceptance....